|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 5/20 | |
| A61K 38/08 | |||
| A61P 13/12 | |||
| A61P 19/00 |
| (11) | Number of the document | 2776129 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12791926.4 |
| Date of filing the European patent application | 2012-11-12 | |
| (97) | Date of publication of the European application | 2014-09-17 |
| (45) | Date of publication and mention of the grant of the patent | 2017-03-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/064717 |
| Date | 2012-11-12 |
| (87) | Number | WO 2013/071262 |
| Date | 2013-05-16 |
| (30) | Number | Date | Country code |
| 201161558389 P | 2011-11-10 | US |
| (72) |
WALTER, Sarah, US
BELL, Gregory, US
TOMLINSON, James, E., US
|
| (73) |
Kai Pharmaceuticals, Inc.,
270 Littlefield Avenue, South San Francisco, CA 94080,
US
|
| (54) | COMPOSITIONS FOR USE IN THE TREATMENT OF CHRONIC KIDNEY DISEASE-MINERAL BONE DISORDER CHARACTERIZED BY SOFT TISSUE CALCIFICATION |
| COMPOSITIONS FOR USE IN THE TREATMENT OF CHRONIC KIDNEY DISEASE-MINERAL BONE DISORDER CHARACTERIZED BY SOFT TISSUE CALCIFICATION |